Credit Suisse Starts Accretive Health (AH) at Outperform

April 13, 2011 12:36 PM EDT
Get Alerts AH Hot Sheet
Price: $8.02 --0%

Rating Summary:
    2 Buy, 6 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Credit Suisse reinstated coverage on Accretive Health (NYSE: AH) with a Outperform rating and $31 price target.

"We are updating our model post restriction following the company's secondary and reinstating coverage with an Outperform rating," said analyst G. Santangelo. "We have made some slight tweaks to our quarterly estimates; however, we note our full year F'11 estimates remains at $0.47. Our new target price of $31 is based on a combination of our discounted cash flow model, price to earnings multiple, and enterprise value to EBITDA multiple."

The recent secondary adds greater liquidity, the firm notes.

For more ratings news on Accretive Health click here and for the rating history of Accretive Health click here.

Shares of Accretive Health closed at $26.75 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

Credit Suisse, Earnings